Emmessar Biotech & Nutrition Limited (BOM:524768)
India · Delayed Price · Currency is INR 23.16
-1.34 (-5.47%)
At close: Sep 25, 2026
BOM:524768 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 0.34 | 0.11 | 0.13 | 0.12 | 1.82 |
Short-Term Investments | - | 72.93 | 68.71 | 61.79 | 51.89 | 44.1 |
Cash & Short-Term Investments | 73.27 | 73.27 | 68.81 | 61.92 | 52 | 45.92 |
Cash Growth | 6.47% | 6.47% | 11.14% | 19.06% | 13.25% | 85.27% |
Accounts Receivable | - | 0.17 | 0.18 | 0.22 | 0.11 | 0.13 |
Other Receivables | - | 2.53 | 2.6 | - | 0.9 | 1.14 |
Receivables | - | 2.94 | 3.08 | 0.36 | 1.1 | 1.33 |
Inventory | - | 0.97 | 1.24 | 0.89 | 1.36 | 0.68 |
Prepaid Expenses | - | 0.91 | 0.93 | 0.96 | 0.67 | 0.55 |
Other Current Assets | - | 2.5 | 1.98 | 4.19 | 4.21 | 0.14 |
Total Current Assets | - | 80.58 | 76.04 | 68.32 | 59.34 | 48.61 |
Property, Plant & Equipment | - | 11.38 | 12.21 | 13.09 | 13.97 | 14.55 |
Long-Term Deferred Tax Assets | - | - | - | - | - | 2.78 |
Other Long-Term Assets | - | 5.84 | 5.93 | 6.02 | 6.12 | 6.19 |
Total Assets | - | 97.8 | 94.18 | 87.43 | 79.43 | 72.14 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 0.06 | 0.03 | 0.09 | - | 0.22 |
Accrued Expenses | - | 4.36 | 3.78 | 3.85 | 3.38 | 2.99 |
Short-Term Debt | - | - | - | 1.09 | 0.82 | - |
Current Income Taxes Payable | - | 1.77 | 2.73 | - | - | - |
Other Current Liabilities | - | 0.17 | 0.17 | - | -0 | 0.09 |
Total Current Liabilities | - | 6.36 | 6.71 | 5.04 | 4.2 | 3.3 |
Pension & Post-Retirement Benefits | - | 1.69 | 1.31 | 1.09 | 1.12 | 1 |
Long-Term Deferred Tax Liabilities | - | 2.78 | 3.15 | 1.13 | 1.32 | - |
Other Long-Term Liabilities | - | 5.84 | 5.94 | 6.14 | 6.14 | 6.14 |
Total Liabilities | - | 16.66 | 17.1 | 13.41 | 12.78 | 10.45 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 49.96 | 49.96 | 49.96 | 49.96 | 49.96 |
Retained Earnings | - | 32.32 | 27.96 | 24.8 | 17.31 | 12.27 |
Comprehensive Income & Other | - | -1.14 | -0.84 | -0.74 | -0.62 | -0.54 |
Shareholders' Equity | 81.15 | 81.15 | 77.08 | 74.02 | 66.65 | 61.69 |
Total Liabilities & Equity | - | 97.8 | 94.18 | 87.43 | 79.43 | 72.14 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | - | - | - | 1.09 | 0.82 | - |
Net Cash (Debt) | 73.27 | 73.27 | 68.81 | 60.82 | 51.18 | 45.92 |
Net Cash Growth | 6.47% | 6.47% | 13.14% | 18.83% | 11.46% | 85.27% |
Net Cash Per Share | 13.60 | 14.67 | 13.77 | 12.17 | 10.24 | 9.19 |
Filing Date Shares Outstanding | 5.06 | 5 | 5 | 5 | 5 | 5 |
Total Common Shares Outstanding | 5.06 | 5 | 5 | 5 | 5 | 5 |
Working Capital | - | 74.23 | 69.34 | 63.28 | 55.14 | 45.31 |
Book Value Per Share | 12.56 | 16.24 | 15.43 | 14.82 | 13.34 | 12.35 |
Tangible Book Value | 81.15 | 81.15 | 77.08 | 74.02 | 66.65 | 61.69 |
Tangible Book Value Per Share | 12.56 | 16.24 | 15.43 | 14.82 | 13.34 | 12.35 |
Buildings | - | 15.4 | 15.4 | 15.4 | 15.4 | 15.4 |
Machinery | - | 5.13 | 5.04 | 5.04 | 5.04 | 4.78 |